Phase II Study on Letrozole in Patients With Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer.

Trial Profile

Phase II Study on Letrozole in Patients With Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2014

At a glance

  • Drugs Letrozole (Primary)
  • Indications Endometrial cancer
  • Focus Therapeutic Use
  • Acronyms deFEND
  • Sponsors Novartis
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register DRKS00003874).
    • 06 Jun 2012 Status changed from suspended to completed as reported by German Clinical Trials Register record.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database, EudraCT2004-003886-34).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top